PT Kalbe Farma Tbk (KLBF) has reaffirmed its strategic steps in integrating Environmental, Social, and Governance (ESG) principles into every line of the company's business activities. This initiative is viewed not merely as regulatory compliance, but as a sustainable effort to support public health and environmental preservation.
Head of Corporate Sustainability at Kalbe, Abi Nisaka, explained that the company has implemented various energy efficiency strategies across its manufacturing facilities. Other concrete steps include the use of eco-friendly packaging, greening initiatives, and the electrification of its motorcycle fleet for health product distribution under the company's logistics unit.
In the social aspect, Kalbe continues to expand access to healthcare services by localizing the production of raw drug materials and medical devices to make them more affordable. The company is also active in educating the public about disease prevention, such as diabetes, and strengthening internal compliance through strict codes of conduct for all employees.
Transparency is a primary focus for Kalbe in maintaining public trust. Through the publication of its annual sustainability report and the provision of dedicated information channels like the kalbecsr.id website, the company ensures that every achievement is widely accessible to stakeholders.
This dedication has yielded tangible results, earning recognition from international institutions. MSCI awarded Kalbe a double-A (AA) rating, while Morningstar Sustainalytics categorized the company as Medium Risk. A number of national awards, such as the Indonesia Sustainability Award 2026 and awards for emissions transparency, further solidify Kalbe's position as a leader in sustainability implementation in the Indonesian healthcare industry.
